Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Inclusion criteria: * A female subject between, and including, 10 and 14 years of age at the time of the first vaccination. * Written informed assent from the subject and informed consent from the parent or guardian of the subject should be obtained prior to enrolment. * Subjects must have a negative urine pregnancy test. * Healthy subject before entering the study as established by medical history and clinical examination. * Subject must be of non-childbearing potential. Exclusion criteria: * Pregnant or breastfeeding. * Previous vaccination against HPV. * Known acute or chronic, clinically significant neurologic, hepatic or renal functional abnormality * History of chronic condition(s) requiring treatment such as cancer, chronic hepatic or kidney disease(s), diabetes, or autoimmune disease."